Crizanlizumab Infusion 10 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Infusion Solution
Available Strengths: 10 mg/mL
Reference Brands: Adakveo(US)
Category: Blood Disorder
Crizanlizumab is a monoclonal antibody that binds to P-selectin, blocking cell adhesion and reducing blood vessel blockages. It decreases the frequency of vaso-occlusive crises in sickle cell disease, offering benefits like improved quality of life, fewer pain episodes, and reduced hospitalizations through targeted, biological therapy.
Product Description: Crizanlizumab, marketed as Adakveo, is approved in both the US by the FDA and in the EU via EMA for reducing vaso-occlusive crises in sickle cell disease. Regulatory approval requires a comprehensive dossier with clinical trial data, safety, efficacy, manufacturing details, and pharmacovigilance plans. In the US, the FDA review involves detailed submission of clinical results, while the EU approval adheres to rigorous regional standards. For expert guidance on dossier preparation, regulatory pathways, and market access strategies, visit PharmaTradz. Ensuring compliance with regional regulations is essential for successful approval, safe use, and commercialization of crizanlizumab infusion solutions worldwide.
Crizanlizumab Infusion — third party manufacturing & bulk supply
Crizanlizumab Infusion 10 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Crizanlizumab Infusion listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Crizanlizumab Infusion →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Anagrelide Hydrochloride
Strength:
0.5 mg
Form: Capsules
Reference Brands: Agrylin (USA)
View Details
Ferric Maltol
Strength:
30 mg
Form: Capsules
Reference Brands: Accrufer (USA), Feraccru (EU)
View Details
Lusutrombopag
Strength:
3 mg
Form: Tablets
Reference Brands: Mulpleta (USA), Mulpleo (EU)
View Details
Quick Response Guaranteed | Verified Suppliers
